Other News To Note
• Cleveland BioLabs Inc., of Buffalo, N.Y., said it submitted a proposal to the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services for funding to complete the development steps needed for FDA licensure of Entolimod as a medical radiation countermeasure.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.